A Phase II Clinical Trial Testing AMG 412 in Combination with Rituxan in Rituximab-Naive Subjects with Refractory or Recurrent Low-Grade, CD20+B-Cell Non-Hodgkin's Lymphoma

  • Howard, Dianna (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/14/01 → 9/12/03